^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ELC-301

i
Other names: ELC-301, ELC301, ELC 301
Associations
Company:
Elicera Therap
Drug class:
CD20-targeted CAR-T immunotherapy
Associations
7ms
CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study) (clinicaltrials.gov)
P1/2, N=18, Recruiting, Uppsala University | Not yet recruiting --> Recruiting
Enrollment open
|
CD20 (Membrane Spanning 4-Domains A1)
|
cyclophosphamide • fludarabine IV • ELC-301